Exozymes (EXOZ) Tax Provisions (2024)

Exozymes (EXOZ) posted quarterly Tax Provisions of -$1.2 million for Q4 2024, down 123302200.0% quarter-over-quarter from -$1.0 in Q3 2024.

Exozymes (EXOZ) Tax Provisions (2024) Analysis & Trends

Exozymes (EXOZ) has reported Tax Provisions for 1 consecutive years, with -$1.2 million the latest figure, recorded in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	59.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	13.31 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	1.90 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Exozymes	62.35 Mn	62.35 Mn	-	-

Download Data